Is oral pristinamycin effective for the treatment of resistant Gram-positive infections as a relay after initial parenteral antimicrobial therapy?
Maladies Infectieuses, AP-HP, Hôpital Universitaire Raymond-Poincaré, Garches 92380, France. Electronic address: benjamin.davido@aphp.fr.
Benjamin
B
Davido
Maladies Infectieuses, AP-HP, Hôpital Universitaire Raymond-Poincaré, Garches 92380, France; Université de Versailles-Saint-Quentin, Saint-Quentin-en-Yvelines F78180, France; UMR 1181, Inserm, Institut Pasteur, Paris, France.
Jérome
J
Salomon
Maladies Infectieuses, AP-HP, Hôpital Universitaire Raymond-Poincaré, Garches 92380, France.
Aurélien
A
Dinh
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004358:Drug Therapy / Q000379:methods; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D025762:Pristinamycin / Q000008:administration & dosage*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D025762:Pristinamycin